Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jun;57(2):301-306.
doi: 10.20471/acc.2018.57.02.10.

Flow Changes in Orbital Vessels Detected with Color Doppler Ultrasound in Patients with Early Dysthyroid Optic Neuropathy

Mladen Lešin  1 , Veljko Rogošić  1 , Lucija Vanjaka Rogošić  2 , Igor Barišić  3 , Goran Pelčić  4
Affiliations

Flow Changes in Orbital Vessels Detected with Color Doppler Ultrasound in Patients with Early Dysthyroid Optic Neuropathy

Mladen Lešin et al. Acta Clin Croat. 2018 Jun.

Abstract

Thyroid-associated orbitopathy (TAO) is a common manifestation of Graves' disease. The aim of the study was to assess the six percent of patients with TAO that develop dysthyroid optic neuropathy (DON), which is the most serious complication of TAO. As DON can cause perma-nent damage, it is essential to detect DON early when visual loss is still reversible. Color Doppler ultrasound is a noninvasive diagnostic method, which may be useful in early detection of DON. Thirty-six patients with confirmed Graves' disease and active TAO were included, 21 (58%) of them with early DON (eDON) and 15 (42%) free from any signs of eDON. All study patients underwent Doppler ultrasound examination to determine the blood flow rates in the internal carotid artery, ophthalmic artery, and central retinal artery. Study results showed color Doppler ultrasound examination to have a potential to detect orbital blood flow changes in patients with eDON. Early detection of DON may result in earlier treatment and prevention of permanent optic nerve damage.

Keywords: Graves’ Disease; Graves’ Ophthalmopathy; Optic Nerve Diseases; Optic Nerve Injuries; Ultrasonography, Doppler, Color.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Ambrosio G, Ferrara G, Vitale R, De Marco R. Visual evoked potentials in patients with Graves’ ophthalmopathy complicated by ocular hypertension and suspect glaucoma or dysthyroid optic neuropathy. Doc Ophthalmol. 2003;106:99–104. 10.1023/A:1022561530782 - DOI - PubMed
    1. Gorman CA. Pathogenesis of Graves’ ophthalmopathy. Thyroid. 1994;4:379–83. 10.1089/thy.1994.4.379 - DOI - PubMed
    1. Riley FC. Orbital pathology in Graves’ disease. Mayo Clin Proc. 1972;47:975–9. - PubMed
    1. Prummel MF, Bakker A, Wiersinga WM, Baldeschi L, Mourits MP, Kendall-Taylor P, et al. Multi-center study on the characteristics and treatment strategies of patients with Graves’ orbitopathy: the first European Group on Graves’ Orbitopathy experience. Eur J Endocrinol. 2003;148:491–5. 10.1530/eje.0.1480491 - DOI - PubMed
    1. Kahaly GJ, Pitz S, Hommel G, Dittmar M. Randomized, single blind trial of intravenous versus oral steroid monotherapy in Graves’ orbitopathy. J Clin Endocrinol Metab. 2005;90:5234–40. 10.1210/jc.2005-0148 - DOI - PubMed

MeSH terms